Related Experiment Videos
[Clinical study on LRH-A contraception by luteolysis]
Zhonghua Fu Chan Ke Za Zhi
|January 1, 1989
Summary
A novel intranasal spray using a gonadotropin-releasing hormone analog (LRH-A) demonstrated a luteolytic effect, offering potential for hormonal contraception. Further research is needed for widespread clinical application.
Area of Science:
- Reproductive Endocrinology
- Pharmacology
Context:
- Investigating novel hormonal contraceptive methods.
- Evaluating the efficacy of gonadotropin-releasing hormone analogs.
- Understanding luteolysis in the context of the menstrual cycle.
Purpose:
- To assess the luteolytic effect of a Chinese-made superactive stimulatory analog of LRH, (D-Ala, des-GLY-EA10)-LRH (LRH-A), for potential contraceptive use.
- To evaluate the safety and efficacy of intranasal LRH-A administration during the luteal phase of the menstrual cycle.
Summary:
- Thirty-eight healthy women received 1 mg/day of intranasal LRH-A from day 15-25 of their cycles for 1-12 cycles.
- Luteolysis, defined as reduced progesterone and a shortened luteal phase, occurred in 154 out of 158 cycles.
- Four pregnancies resulted from administration errors; no severe side effects were noted, and menstrual cycles normalized post-treatment.
Impact:
- LRH-A shows promising luteolytic potential for a new contraceptive approach.
- The study highlights the need for further clinical investigation to establish LRH-A's role in contraceptive practice.
- Intranasal administration offers a potentially convenient delivery method for hormonal therapies.